IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Ask Genius
Apps
News
Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars
Brands
Yourlist
Quizie
F
FaithTap
B
Blessed
All brands
Ask Genius
Apps
Trending
📊 Approval movers
Gordon Liu
100%
Commentary: NYT Reporter Rocks Psaki with Facts After Biden Falsely Takes Credit for Vaccine Deal
Reporting
— Mar 4, 2021
A New York Times reporter called out the Biden administration in a news conference for attempting to take credit for the deal between rival pharmaceutical companies Johnson & Johnson and Merck & Co. to help manufacture…
Share
Biden Says Will Have Enough COVID-19 Vaccine for Every US Adult By May
Reporting
— Mar 3, 2021
The United States will have enough COVID-19 vaccine for every American adult by the end of May, President Joe Biden said on Tuesday after Merck & Co agreed to make rival Johnson & Johnson’s inoculation. The partnership…
Share
Gilead, Merck Report Weekly HIV Trial Results
Health
— Jul 21, 2026
Gilead Sciences and Merck reported positive Phase 3 results for their once-weekly oral HIV regimen combining islatravir and lenacapavir, showing non-inferiority to existing daily therapies and maintaining viral suppression through 48 weeks in virologically suppressed patients. The ISLEND-1 and ISLEND-2 trials suggest this two-drug regimen could become the first complete weekly HIV treatment, with a safety profile generally comparable to current options and plans for regulatory submissions.
+3
Share
Merck Anti-COVID Pill Will Not Be Added to India's National Treatment Protocol
Reporting
— Jan 9, 2022
One of India’s top health officials made major news last week with an announcement about safety concerns regarding an experimental treatment for COVID-19. Director-General of the Indian Council of Medical Research…
Share
IJR
Federal Court Dismisses Pro-Abortion Groups’ Lawsuit Seeking To Ensure Access To Public Funds
Spencer Lombardo · 4 min · 1h
Melanoma Trial Shows Positive Personalized mRNA Vaccine
x/moderna
— Aug 19, 2026
Merck and Moderna reported positive Phase 3 results for their personalized mRNA cancer vaccine intismeran autogene (V940/mRNA-4157) added to Keytruda in high-risk, surgically treated melanoma, showing longer recurrence-free survival and reduced distant metastasis with no new safety issues. The companies plan regulatory discussions and potential accelerated approval submissions, with data presentations at upcoming medical meetings and continued follow-up for overall survival.
+540
Share
Yourlist
Ranking
Most Influential Women in World History
From ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.
1379 votes · 26 candidates
